Symbols / DRIO Stock $7.50 -1.32% DarioHealth Corp.

Healthcare • Health Information Services • United States • NCM
DRIO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Erez Raphael
Exch · Country NCM · United States
Market Cap 54.84M
Enterprise Value 64.86M
Income -40.31M
Sales 22.36M
FCF (ttm) -11.20M
Book/sh 9.84
Cash/sh 3.56
Employees 160
Insider 10d —
IPO Mar 14, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -11.03
PEG —
P/S 2.45
P/B 0.76
P/C —
EV/EBITDA -1.94
EV/Sales 2.90
Quick Ratio 3.08
Current Ratio 3.76
Debt/Eq 46.74
LT Debt/Eq —
EPS (ttm) -8.50
EPS next Y -0.68
EPS Growth —
Revenue Growth -31.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-14
Earnings (prior) 2026-05-13
ROA -20.01%
ROE -59.62%
ROIC —
Gross Margin 64.11%
Oper. Margin -163.68%
Profit Margin -186.56%
Shs Outstand 7.31M
Shs Float 5.26M
Insider Own 21.12%
Instit Own 10.82%
Short Float 0.94%
Short Ratio 3.96
Short Interest 66.95K
52W High 17.74
vs 52W High -57.73%
52W Low 5.93
vs 52W Low 26.37%
Beta 1.09
Impl. Vol. —
Rel Volume 0.40
Avg Volume 12.45K
Volume 5.03K
Target (mean) $18.50
Tgt Median $18.00
Tgt Low $10.00
Tgt High $28.00
# Analysts 4
Recom None
Prev Close $7.60
Price $7.50
Change -1.32%
About

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$18.50
Mean price target
2. Current target
$7.50
Latest analyst target
3. DCF / Fair value
$-27.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.50
Low
$10.00
High
$28.00
Mean
$18.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-14 reit Stifel Buy → Buy $10
2026-05-13 main TD Cowen Hold → Hold $11
2026-03-20 main Stifel Buy → Buy $10
2025-05-19 init Litchfield Hills — → Buy $3
2025-03-11 main Stifel Buy → Buy $2
2024-04-01 main Stifel Buy → Buy $4
2023-08-11 main Alliance Global Partners Buy → Buy $4
2023-07-25 main Stifel Buy → Buy $6
2023-05-12 main Craig-Hallum Buy → Buy $8
2022-11-16 main Alliance Global Partners — → Buy $8
2022-08-18 main Aegis Capital — → Buy $15
2022-08-16 main Cowen & Co. — → Outperform $14
2022-05-16 main Aegis Capital — → Buy $20
2022-05-16 main Cowen & Co. — → Outperform $18
2022-05-13 up Alliance Global Partners Neutral → Buy —
2022-01-26 main Aegis Capital — → Buy $25
2021-08-19 main Aegis Capital — → Buy $28
2021-04-22 init Cowen & Co. — → Outperform $31
2021-03-23 init Stifel — → Buy $30
2021-02-08 main Aegis Capital — → Buy $35
News
RSS: Latest DRIO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-11 MCGRATH DENNIS M Director — 20,000 $0.00 $0
2025-09-11 STERN ADAM K. Director — 20,000 $0.00 $0
2025-09-11 KARAH HILA Director — 20,000 $0.00 $0
2025-09-11 LEISURE LAWRENCE B. Director — 20,000 $0.00 $0
2025-09-11 RAPHAEL EREZ Chief Executive Officer — 60,000 $0.00 $0
2025-09-11 SHAKED YOAV Director — 20,000 $0.00 $0
2025-09-11 FRANCO-YEHUDA CHEN Chief Financial Officer — 5,000 $0.00 $0
2025-09-11 MATHEIS DENNIS Director — 20,000 $0.00 $0
2025-09-11 NELSON STEVEN CHARLES President — 30,000 $0.00 $0
2025-08-27 NELSON STEVEN CHARLES President — 40,000 $0.53 $21,200
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
22.36
-17.31%
27.04
+32.86%
20.35
-26.41%
27.66
Operating Revenue
22.36
-17.31%
27.04
+32.86%
20.35
-26.41%
27.66
Cost Of Revenue
9.69
-29.62%
13.77
-4.14%
14.37
-20.18%
18.00
Reconciled Cost Of Revenue
9.69
-29.62%
13.77
-4.14%
14.37
-20.18%
18.00
Gross Profit
12.66
-4.54%
13.27
+121.71%
5.98
-38.02%
9.65
Operating Expense
49.32
-30.55%
71.01
+14.22%
62.17
-6.46%
66.47
Research And Development
13.79
-42.96%
24.18
+19.41%
20.25
+3.05%
19.65
Selling General And Administration
35.53
-24.14%
46.83
+11.70%
41.92
-10.45%
46.82
Selling And Marketing Expense
20.34
-22.82%
26.35
+10.78%
23.79
-21.56%
30.32
General And Administrative Expense
15.19
-25.83%
20.48
+12.91%
18.14
+9.99%
16.49
Other Gand A
15.19
-25.83%
20.48
+12.91%
18.14
+9.99%
16.49
Total Expenses
59.01
-30.39%
84.78
+10.77%
76.54
-9.38%
84.47
Operating Income
-36.66
+36.52%
-57.74
-2.77%
-56.19
+1.09%
-56.81
Total Operating Income As Reported
-36.66
+36.52%
-57.74
-2.77%
-56.19
+1.09%
-56.81
EBITDA
-35.45
+4.63%
-37.17
+27.40%
-51.20
+7.90%
-55.60
Normalized EBITDA
-36.76
+31.43%
-53.60
-3.68%
-51.70
+8.09%
-56.25
Reconciled Depreciation
3.14
-57.75%
7.43
+48.99%
4.99
+5.68%
4.72
EBIT
-38.59
+13.48%
-44.60
+20.63%
-56.19
+6.84%
-60.31
Total Unusual Items
1.30
-92.06%
16.43
+3205.84%
0.50
-24.24%
0.66
Total Unusual Items Excluding Goodwill
1.30
-92.06%
16.43
+3205.84%
0.50
-24.24%
0.66
Special Income Charges
-0.10
-45.71%
-0.07
0.00
—
Other Special Charges
0.10
+45.71%
0.07
—
—
Net Income
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Pretax Income
-41.61
+6.70%
-44.60
+24.87%
-59.36
+4.54%
-62.19
Net Non Operating Interest Income Expense
-6.26
-90.50%
-3.29
+10.51%
-3.67
+39.17%
-6.04
Interest Expense Non Operating
3.02
0.00
0.00
-100.00%
1.88
Net Interest Income
-6.26
-90.50%
-3.29
+10.51%
-3.67
+39.17%
-6.04
Interest Expense
3.02
0.00
0.00
-100.00%
1.88
Interest Income Non Operating
0.94
-15.50%
1.12
-40.26%
1.87
+269.17%
0.51
Interest Income
0.94
-15.50%
1.12
-40.26%
1.87
+269.17%
0.51
Other Income Expense
1.30
-92.06%
16.43
+3205.84%
0.50
-24.24%
0.66
Gain On Sale Of Security
1.41
-91.48%
16.50
+3219.92%
0.50
-24.24%
0.66
Tax Provision
0.10
+105.67%
-1.85
-2993.75%
0.06
+1500.00%
0.00
Tax Rate For Calcs
0.00
+405.71%
0.00
-80.23%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.27
-59.86%
0.68
+553.70%
0.10
-24.24%
0.14
Net Income Including Noncontrolling Interests
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Net Income From Continuing Operation Net Minority Interest
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Net Income From Continuing And Discontinued Operation
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Net Income Continuous Operations
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Normalized Income
-42.74
+26.93%
-58.49
+2.21%
-59.82
+4.61%
-62.71
Net Income Common Stockholders
-61.73
-50.64%
-40.98
+35.47%
-63.51
+0.51%
-63.84
Diluted EPS
-10.12
+17.52%
-12.27
+68.21%
-38.60
+24.02%
-50.80
Basic EPS
-10.12
+17.52%
-12.27
+68.21%
-38.60
+24.02%
-50.80
Basic Average Shares
3.98
+62.44%
2.45
+72.84%
1.42
+20.04%
1.18
Diluted Average Shares
3.98
+62.44%
2.45
+72.84%
1.42
+20.04%
1.18
Diluted NI Availto Com Stockholders
-61.73
-50.64%
-40.98
+35.47%
-63.51
+0.51%
-63.84
Preferred Stock Dividends
20.02
+1234.33%
-1.76
-143.22%
4.08
+148.57%
1.64
Total Other Finance Cost
4.18
-5.00%
4.40
-20.55%
5.54
+18.74%
4.67
Line Item Trend 2023-12-31
Total Assets
96.39
Current Assets
47.33
Cash Cash Equivalents And Short Term Investments
36.80
Cash And Cash Equivalents
36.80
Other Short Term Investments
0.00
Receivables
3.64
Accounts Receivable
3.15
Gross Accounts Receivable
—
Allowance For Doubtful Accounts Receivable
—
Other Receivables
0.49
Loans Receivable
—
Inventory
5.06
Raw Materials
1.01
Finished Goods
4.05
Prepaid Assets
1.54
Restricted Cash
0.29
Total Non Current Assets
49.06
Net PPE
1.87
Gross PPE
3.35
Accumulated Depreciation
-1.49
Properties
0.00
Machinery Furniture Equipment
1.07
Other Properties
1.96
Leases
0.33
Goodwill And Other Intangible Assets
47.04
Goodwill
41.64
Other Intangible Assets
5.40
Non Current Prepaid Assets
0.01
Other Non Current Assets
0.14
Total Liabilities Net Minority Interest
38.24
Current Liabilities
12.49
Payables And Accrued Expenses
3.36
Payables
1.13
Accounts Payable
1.13
Current Accrued Expenses
2.23
Pensionand Other Post Retirement Benefit Plans Current
4.07
Current Debt And Capital Lease Obligation
4.07
Current Debt
3.95
Other Current Borrowings
3.95
Current Capital Lease Obligation
0.11
Current Deferred Liabilities
1.00
Current Deferred Revenue
1.00
Total Non Current Liabilities Net Minority Interest
25.75
Long Term Debt And Capital Lease Obligation
25.48
Long Term Debt
24.59
Long Term Capital Lease Obligation
0.89
Other Non Current Liabilities
0.04
Stockholders Equity
58.14
Common Stock Equity
58.14
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
1.36
Ordinary Shares Number
1.36
Treasury Shares Number
0.00
Additional Paid In Capital
407.50
Retained Earnings
-349.36
Total Equity Gross Minority Interest
58.14
Total Capitalization
82.73
Working Capital
34.84
Invested Capital
86.69
Total Debt
29.54
Net Debt
—
Capital Lease Obligations
1.00
Net Tangible Assets
11.10
Tangible Book Value
11.10
Derivative Product Liabilities
0.24
Preferred Shares Number
0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-25.94
+32.73%
-38.56
-26.94%
-30.38
+36.51%
-47.84
Cash Flow From Continuing Operating Activities
-25.94
+32.73%
-38.56
-26.94%
-30.38
+36.51%
-47.84
Net Income From Continuing Operations
-41.71
+2.42%
-42.75
+28.07%
-59.43
+4.45%
-62.19
Depreciation Amortization Depletion
3.14
-57.75%
7.43
+48.99%
4.99
+5.68%
4.72
Depreciation
0.31
-76.87%
1.33
+180.55%
0.47
+32.87%
0.36
Amortization Cash Flow
2.83
-53.59%
6.10
+35.20%
4.51
+3.46%
4.36
Depreciation And Amortization
3.14
-57.75%
7.43
+48.99%
4.99
+5.68%
4.72
Amortization Of Intangibles
2.83
-53.59%
6.10
+35.20%
4.51
+3.46%
4.36
Other Non Cash Items
3.56
+5664.06%
-0.06
-106.68%
0.96
-73.05%
3.56
Stock Based Compensation
9.37
-40.71%
15.80
-19.82%
19.70
+16.06%
16.98
Operating Gains Losses
-1.68
+89.81%
-16.50
-2363.28%
-0.67
—
Gain Loss On Investment Securities
-1.68
+89.81%
-16.50
-2363.28%
-0.67
—
Change In Working Capital
1.39
+156.28%
-2.47
-160.63%
4.07
+137.38%
-10.90
Change In Receivables
2.64
+65.25%
1.60
-43.56%
2.83
+155.49%
-5.11
Changes In Account Receivables
2.66
+58.33%
1.68
-48.48%
3.26
+163.87%
-5.11
Change In Inventory
0.44
+41.88%
0.31
-89.36%
2.89
+267.48%
-1.73
Change In Payables And Accrued Expense
-0.90
+77.33%
-3.98
-174.98%
-1.45
+64.72%
-4.10
Change In Payable
-0.90
+77.33%
-3.98
-174.98%
-1.45
+64.72%
-4.10
Change In Account Payable
-0.12
+75.40%
-0.50
+58.35%
-1.19
+57.27%
-2.79
Change In Other Working Capital
-0.87
-457.05%
-0.16
+51.70%
-0.32
-358.40%
0.12
Change In Other Current Assets
0.42
-53.58%
0.91
+279.50%
0.24
+126.01%
-0.92
Change In Other Current Liabilities
-0.34
+70.35%
-1.15
-827.42%
-0.12
-114.89%
0.83
Investing Cash Flow
-4.34
+51.40%
-8.93
-1533.27%
-0.55
+4.54%
-0.57
Cash Flow From Continuing Investing Activities
-4.34
+51.40%
-8.93
-1533.27%
-0.55
+4.54%
-0.57
Net PPE Purchase And Sale
-0.14
-2.90%
-0.14
+76.37%
-0.58
-32.13%
-0.44
Purchase Of PPE
-0.14
-2.90%
-0.14
+76.37%
-0.58
-32.13%
-0.44
Capital Expenditure
-0.14
-2.90%
-0.14
+76.37%
-0.58
-1.92%
-0.57
Net Investment Purchase And Sale
-4.20
0.00
-100.00%
0.04
0.00
Purchase Of Investment
-4.20
0.00
+100.00%
-5.00
0.00
Sale Of Investment
—
0.00
-100.00%
5.03
0.00
Net Business Purchase And Sale
0.00
+100.00%
-8.80
0.00
0.00
Purchase Of Business
0.00
+100.00%
-8.80
0.00
0.00
Net Intangibles Purchase And Sale
—
—
0.00
+100.00%
-0.13
Purchase Of Intangibles
—
—
0.00
+100.00%
-0.13
Net Other Investing Changes
—
—
—
—
Financing Cash Flow
24.31
-36.90%
38.53
+111.09%
18.25
-70.53%
61.94
Cash Flow From Continuing Financing Activities
24.31
-36.90%
38.53
+111.09%
18.25
-70.53%
61.94
Net Issuance Payments Of Debt
0.18
0.00
-100.00%
1.77
-92.55%
23.79
Issuance Of Debt
31.70
0.00
-100.00%
29.60
+24.46%
23.79
Repayment Of Debt
-31.52
0.00
+100.00%
-27.83
0.00
Long Term Debt Issuance
31.70
0.00
-100.00%
29.60
+24.46%
23.79
Long Term Debt Payments
-31.52
0.00
+100.00%
-27.83
0.00
Net Long Term Debt Issuance
0.18
0.00
-100.00%
1.77
-92.55%
23.79
Net Common Stock Issuance
17.37
0.00
-100.00%
1.61
-95.77%
38.15
Common Stock Payments
—
—
0.00
+100.00%
-0.13
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.13
Proceeds From Stock Option Exercised
—
—
—
0.00
Changes In Cash
-5.97
+33.41%
-8.96
+29.26%
-12.67
-193.72%
13.52
Effect Of Exchange Rate Changes
0.01
+113.24%
-0.07
0.00
—
Beginning Cash Position
27.76
-24.55%
36.80
-25.62%
49.47
+37.62%
35.95
End Cash Position
21.80
-21.47%
27.76
-24.55%
36.80
-25.62%
49.47
Free Cash Flow
-26.08
+32.60%
-38.70
-24.99%
-30.96
+36.05%
-48.42
Interest Paid Supplemental Data
3.49
-11.05%
3.93
-2.58%
4.03
+114.87%
1.88
Common Stock Issuance
17.37
0.00
-100.00%
1.61
-95.78%
38.29
Issuance Of Capital Stock
24.13
-37.38%
38.53
+133.78%
16.48
-56.95%
38.29
Net Preferred Stock Issuance
6.75
-82.47%
38.53
+159.15%
14.87
0.00
Preferred Stock Issuance
6.75
-82.47%
38.53
+159.15%
14.87
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category